https://www.ipsen.com/ | Subdomain | IMG-ALT Home |
/press-release/ | Subdomain | Press Releases |
/media-statements/ | Subdomain | Media Statements |
/media-library/ | Subdomain | Media Library |
/general/our-2023-integrated-a... | Subdomain | Our 2023 Integrated Annual Report is live! |
https://www.ipsen.com/investors/ | Subdomain | Investors |
/investors/financial-results/ | Subdomain | Financial Results |
/investors/corporate-news/ | Subdomain | Corporate News |
/investors/financial-calendar/ | Subdomain | Financial Calendar |
/investors/investor-events/ | Subdomain | Investor Events |
/investors/reports-and-accounts/ | Subdomain | Reports and Accounts |
/investors/regulated-information/ | Subdomain | Regulated Information |
/general/financial-results-for... | Subdomain | Financial results for the first half of 2024 |
/shareholdersmeet/2024-annual-... | Subdomain | 2024 Annual General Meeting |
https://www.ipsen.com/partnering/ | Subdomain | Partnering |
https://www.ipsen.com/careers/ | Subdomain | Careers |
/careers/working-at-ipsen/ | Subdomain | Working at Ipsen |
/careers/our-culture/ | Subdomain | Culture |
https://www.ipsen.com/ | Subdomain | English EN |
https://www.ipsen.com/fr/ | Subdomain | Français FR |
https://www.ipsen.com/ | Subdomain | EnglishEN |
https://www.ipsen.com/fr/ | Subdomain | FrançaisFR |
https://www.ipsen.com/ | Subdomain | Global |
https://www.ipsen.com/ | Subdomain | EN |
https://www.ipsen.com/fr | Subdomain | FR |
/annualreport | Subdomain | Annual Report |
/annualreport | Subdomain Textduplikat | EN |
/annualreport/fr | Subdomain Textduplikat | FR |
https://www.ipsen.com/us/ | Neues Fenster Subdomain | United States |
https://www.ipsen.com/brazil/ | Neues Fenster Subdomain | Brazil |
https://www.ipsen.com/canadaen/ | Neues Fenster Subdomain | Canada EN |
https://www.ipsen.com/canadafr/ | Neues Fenster Subdomain | Canada FR |
https://www.ipsen.com/aus/ | Neues Fenster Subdomain | Australia |
https://www.ipsen.cn/ | Neues Fenster Extern Subdomain | China |
https://www.ipsen.com/singapore/ | Neues Fenster Subdomain | Singapore |
https://www.ipsen.com/korea/ | Neues Fenster Subdomain | South Korea |
https://www.ipsen.com/japan/ | Neues Fenster Subdomain | Japan |
https://www.ipsen.com/be/ | Neues Fenster Subdomain | Belgium |
https://www.ipsen.com/ukraine/ | Neues Fenster Subdomain | Ukraine |
https://www.ipsen.com/uk-ireland/ | Neues Fenster Subdomain | UK |
https://www.ipsen.com/germany/ | Neues Fenster Subdomain | Germany |
https://www.ipsen.com/france/ | Neues Fenster Subdomain | France |
https://www.ipsennordic.com/ | Neues Fenster Extern Subdomain | Nordics |
https://www.ipsen.com/greece/ | Neues Fenster Subdomain | Greece |
https://www.ipsen.com/it/ | Neues Fenster Subdomain | Italy |
/netherlands/ | Neues Fenster Subdomain | Netherlands |
https://www.ipsen.com/spain/ | Neues Fenster Subdomain | Spain |
https://www.ipsen.com/poland/ | Neues Fenster Subdomain | Poland |
https://www.ipsen.com/russia/ | Neues Fenster Subdomain | Russia |
https://www.ipsen.com/czc/ | Neues Fenster Subdomain | Czech Republic |
/switzerland/ | Neues Fenster Subdomain | Switzerland |
https://www.ipsen.com/ | Subdomain Textduplikat | Home |
https://www.ipsen.com/company/ | Subdomain | Company |
/company/leadership-team/ | Subdomain | Leadership |
/company/history/ | Subdomain | History |
/company/foundation-ipsen/ | Subdomain | Fondation Ipsen |
https://www.ipsen.com/oncology/ | Subdomain | Oncology |
/rare-diseases/ | Subdomain | Rare Disease |
/neuroscience/ | Subdomain | Neuroscience |
/our-products/ | Subdomain | Products |
/research-and-development/ | Subdomain | R&D |
https://www.ipsen.com/pipeline/ | Subdomain | Pipeline |
/clinical-trials/ | Subdomain | Clinical Trials |
/responsibility/ | Subdomain | Responsibility |
/responsibility/environment/ | Subdomain | Environment |
/responsibility/patients/ | Subdomain | Patients |
/responsibility/people/ | Subdomain | People |
/responsibility/governance/ | Subdomain | Governance |
/responsibility/our-standards/ | Subdomain | Our Standards |
https://www.ipsen.com/patients/ | Subdomain Textduplikat | Patients |
/patients/together-for-oncology/ | Subdomain | Together for Oncology |
/patients/together-for-rare-di... | Subdomain | Together for Rare Disease |
/patients/together-for-neurosc... | Subdomain | Together for Neuroscience |
/patients/lay-summaries/ | Subdomain | Lay Summaries |
/patients/collaborate-with-us/ | Subdomain | Collaborate with us |
https://www.ipsen.com/stories/ | Subdomain | Stories |
https://www.ipsen.com/company/ | Subdomain | Learn about our strategy |
https://www.ipsen.com/careers/ | Subdomain | Trivialer Linktext Read more |
https://www.ipsen.com/partnering/ | Subdomain | Find out more |
/research-and-development/ | Subdomain | Learn more |
/research-and-development/ | Subdomain Textduplikat | Learn more |
/press-releases/ipsen-receives... | Subdomain | Kein Text |
/press-releases/ipsen-receives... | Subdomain | Kein Text |
/press-releases/ipsen-receives... | Subdomain | Rare Diseases – 26 July 2024 Ipsen receives CHMP positive opinions for Iqirvo® (elafibranor) in Primary Biliary Cholangitis and Kayfanda® (odevixibat)… |
/press-releases/ipsen-delivers... | Subdomain | Kein Text |
/press-releases/ipsen-delivers... | Subdomain | Kein Text |
/press-releases/ipsen-delivers... | Subdomain | Financial – 25 July 2024 Ipsen delivers strong results in the first half of 2024, progresses on launches and upgrades… |
/press-releases/ipsen-and-day-... | Subdomain | Kein Text |
/press-releases/ipsen-and-day-... | Subdomain | Kein Text |
/press-releases/ipsen-and-day-... | Subdomain | Partnering – 25 July 2024 Ipsen and Day One enter into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the… |
/press-releases/ipsen-and-fore... | Subdomain | Kein Text |
/press-releases/ipsen-and-fore... | Subdomain | Kein Text |
/press-releases/ipsen-and-fore... | Subdomain | Partnering – 11 July 2024 Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class pote... |
/press-releases/ipsens-iqirvo-... | Subdomain | Kein Text |
/press-releases/ipsens-iqirvo-... | Subdomain | Kein Text |
/press-releases/ipsens-iqirvo-... | Subdomain | Rare Diseases – 10 June 2024 Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary… |
/press-releases/ipsen-presents... | Subdomain | Kein Text |
/press-releases/ipsen-presents... | Subdomain | Kein Text |
/press-releases/ipsen-presents... | Subdomain | Rare Diseases – 05 June 2024 Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary… |
/general/our-2023-integrated-a... | Subdomain | Kein Text |
/general/our-2023-integrated-a... | Subdomain | Kein Text |
/general/our-2023-integrated-a... | Subdomain | General – 31 May 2024 Our 2023 Integrated Annual Report is live! |
https://www.ipsen.com/oncology/ | | Oncology Ipsen has been working in oncology since 1986, and now has a portfolio that includes treatments for neuroendocrine tumor (NETs), and cancers of the ... |
/rare-diseases/ | | Rare Disease Ninety-four percent of rare medical conditions still have no treatment. We are committed to finding treatments for extremely rare bone diseases ... |
/neuroscience/ | | Neuroscience Ipsen draws on 30 years of expertise in toxins and neuroscience research to support children and adults suffering from debilitating and degenera... |
https://www.ipsen.com/patients/ | Subdomain Textduplikat | Learn more |
/responsibility/ | Subdomain Textduplikat | Learn more |
https://www.ipsen.com/careers/ | Subdomain | Explore careers at Ipsen |
/responsibility/winning-togeth... | Subdomain | IMG-ALT Winning Together at Ipsen A-TITLE Winning Together at Ipsen |
/responsibility/winning-togeth... | Subdomain Textduplikat | Winning Together at Ipsen A-TITLE Winning Together at Ipsen |
/financial-results/strong-grow... | Subdomain | IMG-ALT Strong growth and expanding pipeline in the first half of 2024 drive raised guidance A-TITLE Strong growth and expanding pipeline in the first half of 2024 drive raised guidance |
/financial-results/strong-grow... | Subdomain Textduplikat | Strong growth and expanding pipeline in the first half of 2024 drive raised guidance A-TITLE Strong growth and expanding pipeline in the first half of 2024 drive raised guidance |
/rare-diseases/how-physicians-... | Subdomain | IMG-ALT How physicians can help empower people living with Primary Biliary Cholangitis A-TITLE How physicians can help empower people living with Primary Biliary Cholangitis |
/rare-diseases/how-physicians-... | Subdomain Textduplikat | How physicians can help empower people living with Primary Biliary Cholangitis A-TITLE How physicians can help empower people living with Primary Biliary Cholangitis |
/general/financial-results-for... | Subdomain Textduplikat | IMG-ALT Financial results for the first half of 2024 A-TITLE Financial results for the first half of 2024 |
/general/financial-results-for... | Subdomain Textduplikat | Financial results for the first half of 2024 A-TITLE Financial results for the first half of 2024 |
/responsibility/ipsen-shines-a... | Subdomain | IMG-ALT Ipsen shines at ESG Life Sciences Summit Europe 2024 A-TITLE Ipsen shines at ESG Life Sciences Summit Europe 2024 |
/responsibility/ipsen-shines-a... | Subdomain Textduplikat | Ipsen shines at ESG Life Sciences Summit Europe 2024 A-TITLE Ipsen shines at ESG Life Sciences Summit Europe 2024 |
/culture/spectra-erg-celebrate... | Subdomain | IMG-ALT Spectra ERG Celebrates its First Anniversary Supporting the LGBTQIA+ Community at Ipsen A-TITLE Spectra ERG Celebrates its First Anniversary Supporting the LGBTQIA+ Community at Ipsen |
/culture/spectra-erg-celebrate... | Subdomain Textduplikat | Spectra ERG Celebrates its First Anniversary Supporting the LGBTQIA+ Community at Ipsen A-TITLE Spectra ERG Celebrates its First Anniversary Supporting the LGBTQIA+ Community at Ipsen |
/rare-diseases/the-importance-... | Subdomain | IMG-ALT The importance of personalized care to empower patients with PBC A-TITLE The importance of personalized care to empower patients with PBC |
/rare-diseases/the-importance-... | Subdomain Textduplikat | The importance of personalized care to empower patients with PBC A-TITLE The importance of personalized care to empower patients with PBC |
/general/our-2023-integrated-a... | Subdomain Textduplikat | IMG-ALT Our 2023 Integrated Annual Report is live! A-TITLE Our 2023 Integrated Annual Report is live! |
/general/our-2023-integrated-a... | Subdomain Textduplikat | Our 2023 Integrated Annual Report is live! A-TITLE Our 2023 Integrated Annual Report is live! |
/oncology/together-we-can-impr... | Subdomain | IMG-ALT Together, we can improve the lives of people living with kidney cancer A-TITLE Together, we can improve the lives of people living with kidney cancer |
/oncology/together-we-can-impr... | Subdomain Textduplikat | Together, we can improve the lives of people living with kidney cancer A-TITLE Together, we can improve the lives of people living with kidney cancer |
/responsibility/ipsens-commitm... | Subdomain | IMG-ALT Ipsen’s Commitment to Biodiversity A-TITLE Ipsen’s Commitment to Biodiversity |
/responsibility/ipsens-commitm... | Subdomain Textduplikat | Ipsen’s Commitment to Biodiversity A-TITLE Ipsen’s Commitment to Biodiversity |
https://www.ipsen.com/stories/ | Subdomain | View all stories A-TITLE View all stories |
/press-release/ | Subdomain | Media |
https://www.ipsen.com/investors/ | Subdomain Textduplikat | Investors |
https://www.ipsen.com/partnering/ | Subdomain Textduplikat | Partnering |
https://www.ipsen.com/careers/ | Subdomain Textduplikat | Careers |
https://www.ipsen.com/company/ | Subdomain Textduplikat | Company |
/responsibility/ | Subdomain Textduplikat | Responsibility |
https://www.ipsen.com/patients/ | Subdomain Textduplikat | Patients |
https://www.ipsen.com/stories/ | Subdomain Textduplikat | Stories |
/annualreport/ | Neues Fenster Subdomain Textduplikat | Annual Report |
https://www.ipsen.com/contact-us/ | Subdomain | Contact us |
https://www.linkedin.com/compa... | Neues Fenster Extern Subdomain | IMG-ALT LinkedIn |
https://twitter.com/ipsengroup | Neues Fenster Extern | IMG-ALT Twitter |
https://www.facebook.com/Ipsen... | Neues Fenster Extern Subdomain | IMG-ALT Facebook |
https://www.instagram.com/ipse... | Neues Fenster Extern Subdomain | IMG-ALT Instagram |
https://www.youtube.com/IpsenB... | Neues Fenster Extern Subdomain | IMG-ALT Youtube |
/terms-and-conditions/ | Subdomain | Terms and Conditions |
/cookie-policy/ | Subdomain | Cookie Policy |
/global-privacy-policy/ | Subdomain | Global Privacy Policy |
(Nice to have)